Cure8 research brief
Perianal fistulas in Crohn’s disease are often hard to treat; this review suggests stem cell therapies can produce durable closure for many patients and appear safe over 1–4 years of follow-up.
Patients with Crohn’s disease and persistent perianal fistulas, colorectal surgeons and IBD clinicians considering advanced therapies, and researchers studying cell-based treatments for IBD complications.
This paper pooled data from 18 studies (750 patients) including randomized trials and observational/early-phase studies, with follow-up from 12 months to 4 years. In the restricted analysis of randomized controlled trials the long-term clinical healing rate was about 59% (95% CI 51%–67%).
An exploratory pooled estimate across all study designs was about 63%, but that mixed different study types. The review reports generally favorable safety outcomes: no treatment-related deaths and no clearly therapy-associated malignancies were identified across included studies.
Observational and early-phase studies showed more variable results and a higher risk of bias compared with RCTs. How to use this information This is a synthesis of available longer-term data, not a treatment guideline.
Patients and clinicians should view these pooled rates as encouraging but influenced by differences in study design, patient selection, and stem cell products used. Discuss individual suitability, product availability, and local expertise with a colorectal specialist or IBD team.
The paper is a systematic review and meta-analysis based on studies through Sept 1, 2024, including RCTs and observational/early-phase trials. The exploratory pooled estimate mixes study designs and should be interpreted cautiously because of heterogeneity and variable risk of bias.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Small-bowel Crohn's disease often causes strictures and fistulas and typically needs more imaging and procedural care than colonic disease, so patients and clinicians should be aware of its distinct risks and treatment...
Setons are often used to control sepsis in complex anal fistula, but this study suggests outcomes are worse when Crohn's disease is present, meaning clinicians may view long-term setons as temporary measures in CD rather...
Perianal fistulas are a common and often challenging complication of Crohn’s disease. This surgical series provides outcome data on draining seton treatment that may help patients and clinicians understand typical...
